Transcutol V

Suppocire® NAI 25 A Pellets is a hard fat suppository base optimized for the formulation of analgesics and antipyretics. Confers high mechanical resistance and yields harder suppository units.

Suppocire® NB Pellets is a hard fat suppository base with intermediate melting point. Confers high mechanical resistance and yields harder suppository units.

Tefose® 1500 (mixture of PEG-6 stearate and PEG-32 stearate) is a  nonionic oil-in-water emulsifier for topical formulations that provides high stability in topical fluid lotions and light emulsions over a wide pH range.

Tefose® 63  (mixture of PEG-6 stearate and ethylene glycol palmitostearate and PEG-32 stearate) is a nonionic oil-in-water emulsifier for topical formulations.  It delivers high stability for a wide range of APIs in emulsions. Widely used in vaginal creams due to high mucosal tolerance.
...

Transcutol® HP (diethylene glycol monoethyl ether) is the highest-purity grade solvent and solubilizer for solubility and bioavailability enhancement for oral and alternative routes (parenteral, nasal, ophthalmic formulations).

Transcutol® P (D=diethylene glycol monoethyl ether) a high-purity solvent and powerful solubilizer associated with skin penetration enhancement in topical dosage forms.

Labrafac™ MC60 (glycerol monocaprylocaprate) is a water-insoluble surfactant used in oral lipid-based formulation for bioavailability enhancement of poorly water-soluble, and poorly permeable drugs. It acts as a solubilizer and as an intestinal permeation enhancer.

Emulfree® Duo is a ready-to-use system. It has been designed to stabilize the oil phase within a bi-gel, an emerging topical formulation, by ensuring fine and homogeneous dispersion in the aqueous phase. As a PEG-free excipient, it is ideal for sensitive skins and mucosea.

Gelucire® 59/14 is a mixture of lauroyl PEG-32 glycerides and PEG 6000 and has surfactant properties. It is a self-emulsifying excipient used for oral bioavailability enhancement of poorly water-soluble drugs, thanks to its high solubilizing capacity.

Capryol 90 (propylene glycol monocaprylate) is a nonionic water-insoluble surfactant used as cosurfactant in oral lipid-based formulation SEDDS and SMEDDS. Cosurfactant and solubilizer in topical dosage forms.

Maisine® CC (glyceryl monolinoleate) is an oil composed of long-chain mono-, di-, and triglycerides for lipid-based formulations to solubilize and increase oral bioavailability of poorly water-soluble lipophilic APIs. Used in self-emulsifying lipid formulations (SEDDS and SMEDDS) as an oily vehicle. Its hi...

Compritol® 888 ATO (glyceryl dibehenate) is a glyceride with a high melting point used as a modified release agent or lubricant in tablets. Can also be used in lipid coating technologies and as lipid carrier for nanoparticles.

Discover Gelucire® 59/14, an add-on in Gattefossé Gelucire® range, for oral bioavailability enhancement

Providing high-quality functional excipients

Our lipid excipients are manufactured using vegetable oils (including corn, apricot kernel or coconut oil), a wide array of plant-derived fatty acids, and alcohols such as polyglycerol, fatty alcohols, polyethylene glycol and propylene glycol.

Depending on the raw materials used, the esterification reaction leads to solid, semi-solid, or liquid excipients. The fatty acid chain length, the composition in terms of mono-, di- and triglycerides and alcohol-esters impact the end-product physico-chemical and functional properties.

 
Find out quickly the excipient you are looking for! This updated version has been enriched with the precedence of use of our excipients.

Discover Labrafac™ MC60, glycerol monocaprylocaprate, an oral bioavailability enhancer.

The four Technical Centers of Excellence of Gattefossé, based in France, the United States, China and India, help our customers worldwide in their formulation projects, from concept to commercialization. Their core missions are to provide technical support, troubleshoot and share their scientific knowledge on the use of lipid-based excipients.

Discover our brand new excipient Emulfree® Duo, a ready-to-use stabilizing agent, enabler of bi-gel, an emerging topical dosage form.